Psychopharmacology and Psychiatry Updates

Un podcast de Psychopharmacology Institute

Catégories:

213 Épisodes

  1. Understanding Safety Risks of Broad-Spectrum Micronutrients

    Publié: 17/03/2024
  2. The Role of Inflammation in Delirium: Can NSAIDs Help?

    Publié: 12/03/2024
  3. Beyond Medication: Exploring Nutritional Psychiatry

    Publié: 07/03/2024
  4. Age Impact on Antidepressant Outcomes

    Publié: 02/03/2024
  5. Dealing With Delirium in Patients With Advanced Cancer

    Publié: 26/02/2024
  6. Rechallenging Clozapine: A Look at Colony Stimulating Factors

    Publié: 21/02/2024
  7. Managing Anxiety in Patients With Cancer

    Publié: 16/02/2024
  8. Managing Antidepressant Side Effects in Youth

    Publié: 11/02/2024
  9. Depressed Patient With Cancer? Here’s How to Treat

    Publié: 06/02/2024
  10. Brexanolone: A Quick Fix for Postpartum Depression and Anxiety?

    Publié: 01/02/2024
  11. The Nitty-Gritty on Treatment Optimization for Tic Disorders in Youth

    Publié: 27/01/2024
  12. Untangling Dilemmas: Youth Cannabis-ADHD-Stimulant Med Misuse

    Publié: 22/01/2024
  13. Tic Disorders and Psychiatric Comorbidities in Youth: Treatment Cheat Sheet

    Publié: 17/01/2024
  14. Clinician’s Digest: CANMAT and Mixed States Practicalities

    Publié: 12/01/2024
  15. Mystery No More: Understanding Tic Disorders in Pediatric Psychiatry

    Publié: 07/01/2024
  16. Metformin for Youth on SGAs: Ready for Prime Time?

    Publié: 02/01/2024
  17. Diagnosing Bipolar Disorder Within a Mood Spectrum? Here’s How

    Publié: 28/12/2023
  18. Zolpidem Is to Blame: Sleepwalking and Sleep-Related Eating Disorder

    Publié: 23/12/2023
  19. Cariprazine: A Good Option for Pediatric Patients?

    Publié: 18/12/2023
  20. Sleepwalking and Sleep Driving: Medication to Be Aware Of

    Publié: 13/12/2023

2 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site